April 15, 2019, 11:47 am

Zymeworks Opens Phase 2 Clinical Trial for ZW25 in First-Line HER2-Expressing Metastatic Gastroesophageal Cancers


 15-04-2019 11:47 AM

VANCOUVER, British Columbia-(BUSINESS WIRE)-Apr 15, 2019-Zymeworks Inc. (NYSE/TSX: ZYME), a clinical-stage biopharmaceutical company developing multifunctional therapeutics, today announced it has initiated its global multicenter Phase 2 clinical trial evaluating ZW25 in combination...

Posted in:
Fort Madison Daily Democrat
Fort Madison Daily Democrat

This article was posted online by Fort Madison Daily Democrat. Spot On Iowa collects excepts of news articles from this news source and add these in the 'Southeast Iowa'-category. For mor einformation about Spot On Iowa, you can check the About Us-page.

This story was posted in the category:




Counties in this region: